Handbook of Clinical medicine

dominant process, but equally may mystify matters still further if we attempt to apply our inadequate classifi ers (‘But why is the ANCA not positive?’ cries the student, enraged at the failure of the miserable patient’s B lymphocytes to do the honourable thing). As ever, management should be individualized dependent on liver and bowel histology, serum immunoglobulin levels, the degree of biochemical cholestasis, cholangiography, and, yes, autoantibodies. Fig 6.31 MRCP showing features of PSC. The intrahe- Fig 6.30 ERCP showing many stric- patic ducts show multifocal strictures. Strictures can tures in the biliary tree with a charac- be hard to diff erentiate from cholangiocarcinoma teristic ‘beaded’ appearance. (coexistence of UC may promote this development). Stenting may be needed. © Dr Anthony Mee. ©Norwich Radiology Department. __OOHHCCMM__1100ee..iinnddbb 228833 0022//0055//22001177 1199::0077 ygoloretneortsaG 284 Autoimmune hepatitis (AIH) An infl ammatory liver disease of unknown cause33 characterized by abnormal T-cell function and autoantibodies directed against hepatocyte surface antigens. Classifi ca- tion is by autoantibodies (see table 6.12). AIH predominantly aff ects young or middle- aged women (bimodal, ie 10–30yrs—or >40yrs old). Up to 40% present with acute hepatitis and signs of autoimmune disease, eg fever, malaise, urticarial rash, polyar- thritis, pleurisy, pulmonary infi ltration,
